131 related articles for article (PubMed ID: 17051710)
1. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Iudina LV; Snezhko VI; Rachko IuV
Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
[TBL] [Abstract][Full Text] [Related]
2. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
3. [Acute exacerbated chronic bronchitis. Antibiotics in comparison].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603610
[No Abstract] [Full Text] [Related]
4. [Moxifloxacin in the treatment of chronic bronchitis--clinical evaluation and assessment by patients].
Lorenz J; Busch W; Thate-Waschke IM;
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():63-70. PubMed ID: 15700488
[TBL] [Abstract][Full Text] [Related]
5. [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
Beloborodova NV; Popov DA; Vostrikova TIu; Bachinskaia EN; Kuznetsova ST
Antibiot Khimioter; 2009; 54(1-2):25-6, 28-30. PubMed ID: 19499714
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI).
Chuchalin A; Zakharova M; Dokic D; Tokić M; Marschall HP; Petri T
BMC Pulm Med; 2013 Jan; 13():5. PubMed ID: 23343427
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.
Pea F; Pavan F; Lugatti E; Dolcet F; Talmassons G; Screm MC; Furlanut M
Clin Pharmacokinet; 2006; 45(3):287-95. PubMed ID: 16509760
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
9. No more equivalence trials for antibiotics in exacerbations of COPD, please.
Miravitlles M; Torres A
Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
[No Abstract] [Full Text] [Related]
10. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2007; 2(3):191-204. PubMed ID: 18229559
[TBL] [Abstract][Full Text] [Related]
12. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
Piercy T; Steward J; Lever MS; Brooks TJ
J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
[TBL] [Abstract][Full Text] [Related]
13. [Highlights of the Congress of the National Infectious Disease Medicine Days 2010].
Wintenberger C
Med Mal Infect; 2011 Jan; 41(1 Suppl 1):H6-10. PubMed ID: 21335253
[No Abstract] [Full Text] [Related]
14. Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.
Miravitlles M; Llor C
Clin Drug Investig; 2007; 27(2):95-104. PubMed ID: 17217314
[TBL] [Abstract][Full Text] [Related]
15. Intravenous moxifloxacin. Even more harmful than the oral form.
Prescrire Int; 2011 Jun; 20(117):151. PubMed ID: 21678703
[No Abstract] [Full Text] [Related]
16. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly.
Boersma WG
Eur Respir J; 2012 Jul; 40(1):1-3. PubMed ID: 22753830
[No Abstract] [Full Text] [Related]
18. Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.
Solèr M; Lode H; Baldwin R; Levine JH; Schreurs AJ; van Noord JA; Maesen FP; Zehrer M;
Eur J Clin Microbiol Infect Dis; 2003 Mar; 22(3):144-50. PubMed ID: 12649711
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
Pacios E; Gestoso I; Villarroel P
Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
